Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAFF |
| Upstream (Parents) |
|---|
| (<<) ACAA1 → MAFF |
| (<<) ECHS1 → MAFF |
| (<<) PRODH2 → MAFF |
| (<<) DCXR → MAFF |
| (<<) GPT → MAFF |
| Downstream (Children) |
|---|
| MAFF → HBEGF (>>) |
| MAFF → IER3 (>>) |
| MAFF → SILV (>>) |
| MAFF → GCDH (>>) |
| MAFF → SERPINB9 (>>) |
| MAFF → FOS (>>) |
| MAFF → GCK (>>) |
| MAFF → CEBPA (>>) |
| MAFF → BRD7P3 (>>) |
| MAFF → SLC25A24 (>>) |
| MAFF → ATF7IP2 (>>) |
| MAFF → TAF1A (>>) |
| MAFF → PLK3 (>>) |
| MAFF → ANXA2P2 (>>) |
| MAFF → ALDOA (>>) |
| MAFF → IL8 (>>) |
| MAFF → TTC9 (>>) |
| MAFF → ENO2 (>>) |
| MAFF → LOC653562///SLC6A10P///SLC6A8 (>>) |
| MAFF → AQP7 (>>) |
| MAFF → IL23A (>>) |
| MAFF → PMAIP1 (>>) |
| MAFF → PKM2 (>>) |
| MAFF → PPP1R15A (>>) |
| MAFF → PLAUR (>>) |
| MAFF → PAM (>>) |
| MAFF → MGMT (>>) |
| MAFF → ADAM9 (>>) |
| MAFF → FANCC (>>) |
| MAFF → STK17B (>>) |
| MAFF → CSDA (>>) |
| MAFF → PFKFB3 (>>) |
